bpc-157 safety regulatory status fda unapproved peptide warning bpc-157 regulatory news regulation 2025

Blood flow regulation May assist in optimizing circulation for enhanced healing

By purchasing this product, the purchaser confirms and agrees that: The product will be handled only by appropriately qualified professionals or accredited research facilities

Reconstitution note: Tesamorelin is strongly cationic and prone to injection-site welts, so reconstitute with 0.9% NaCl bacteriostatic water rather than plain BAC water the sodium and chloride ions screen the peptides charge and shrink the welt

AOD-9604 may theoretically interact with beta-blockers by antagonising beta-3 receptor signalling, though this hasnt been clinically documented